4-amino-3-benzyl-4,5-dihydro-1H-1,2,4-triazole-5-thione, 95+%, 250mg

4,6-Dichloro-5-nitro-2-(propylthio)pyrimidine, 95.0%, 5g

Oxazole-4-carbaldehyde, 95.0%, 50g

4-Phenylbutylamine Hydrochloride>98.0%(HPLC)(N)25g

(R)-1-Benzyl-6-hydroxymethyl-piperazin-2-one, 97.0%, 250mg

BICYCLO[3.2.1]OCTAN-3-AMINE HCL, 95.0%, 250mg

4-Chloro-7-methoxy-2-phenylquinoline, 98.0%, 25g

2-[2-(Morpholine-4-sulfonyl)ethyl]-2,3-dihydro-1H-isoindole-1,3-dione, 97%, 1g

1,3,5-Tris(3,5-di-tert-butyl-4-hydroxybenzyl)-1,3,5-triazinane-2,4,6-trione, 98%, 100g

Potassium ethyl xanthate, 80.0%, 25g

N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1R,2R)-2-(dimethylamino)cyclohexyl]urea, 97%, 1g

5,5'-Dibromo-4,4'-ditetradecyl-2,2'-bithiophene, 98%, 1g

Phase contrast Abbe condenser with slide for Plan PLPHi S40 phase contrast infinity corrected objectives, slide with 40x phasing, telescope and green filter